Buy or sell Miroculus stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Miroculus Stock
Miroculus is a hands off sample-to-answer solution for molecular testing.
About Miroculus Stock
Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
Funding History
| January 2014 | $0 |
|---|---|
| September 2014 | $500K |
| April 2015 | $2.3M |
| May 2016 | $50K |
| October 2016 | $0 |
| August 2018 | $17.2M |
Management
CTO
Jorge Soto
Chief Scientific Officer
Foteini Christodoulou
CEO
Alejandro Tocigl
Other Companies
Learn More
Learn More
Tute Genomics
Cloud-based genomics testing platform
9Age (years)
$7.7MTotal Funding
Learn More
Learn More
ZappRx
Prescription & Prior Authorization Platform
9Age (years)
$41.0MTotal Funding
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Miroculus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
